Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma (Q67453794)
Jump to navigation
Jump to search
scientific article published on 01 January 1978
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma |
scientific article published on 01 January 1978 |
Statements
Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma (English)
H. H. Peter
K. E. Deutschmann
J. Deinhardt
1 January 1978